Literature DB >> 33159009

Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.

Kevin W Ng1, Nikhil Faulkner1, Georgina H Cornish1, Annachiara Rosa2, Ruth Harvey3, Saira Hussain3, Rachel Ulferts4, Christopher Earl5, Antoni G Wrobel6, Donald J Benton6, Chloe Roustan7, William Bolland1, Rachael Thompson1, Ana Agua-Doce8, Philip Hobson8, Judith Heaney9, Hannah Rickman9, Stavroula Paraskevopoulou9, Catherine F Houlihan9,10, Kirsty Thomson9, Emilie Sanchez9, Gee Yen Shin9, Moira J Spyer9,11, Dhira Joshi12, Nicola O'Reilly12, Philip A Walker7, Svend Kjaer7, Andrew Riddell8, Catherine Moore13, Bethany R Jebson14,15, Meredyth Wilkinson14,15, Lucy R Marshall14,15, Elizabeth C Rosser14,16, Anna Radziszewska14,16, Hannah Peckham14,16, Coziana Ciurtin14,16, Lucy R Wedderburn14,15, Rupert Beale4, Charles Swanton17, Sonia Gandhi18, Brigitta Stockinger19, John McCauley3, Steve J Gamblin6, Laura E McCoy20, Peter Cherepanov21, Eleni Nastouli22,11, George Kassiotis23,24.   

Abstract

Zoonotic introduction of novel coronaviruses may encounter preexisting immunity in humans. Using diverse assays for antibodies recognizing SARS-CoV-2 proteins, we detected preexisting humoral immunity. SARS-CoV-2 spike glycoprotein (S)-reactive antibodies were detectable using a flow cytometry-based method in SARS-CoV-2-uninfected individuals and were particularly prevalent in children and adolescents. They were predominantly of the immunoglobulin G (IgG) class and targeted the S2 subunit. By contrast, SARS-CoV-2 infection induced higher titers of SARS-CoV-2 S-reactive IgG antibodies targeting both the S1 and S2 subunits, and concomitant IgM and IgA antibodies, lasting throughout the observation period. SARS-CoV-2-uninfected donor sera exhibited specific neutralizing activity against SARS-CoV-2 and SARS-CoV-2 S pseudotypes. Distinguishing preexisting and de novo immunity will be critical for our understanding of susceptibility to and the natural course of SARS-CoV-2 infection.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33159009      PMCID: PMC7857411          DOI: 10.1126/science.abe1107

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  35 in total

Review 1.  MHVR-independent cell-cell spread of mouse hepatitis virus infection requires neutral pH fusion.

Authors:  T C Nash; T M Gallagher; M J Buchmeier
Journal:  Adv Exp Med Biol       Date:  1995       Impact factor: 2.622

2.  Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review.

Authors:  Riccardo Castagnoli; Martina Votto; Amelia Licari; Ilaria Brambilla; Raffaele Bruno; Stefano Perlini; Francesca Rovida; Fausto Baldanti; Gian Luigi Marseglia
Journal:  JAMA Pediatr       Date:  2020-09-01       Impact factor: 16.193

3.  Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.

Authors:  Jan ter Meulen; Edward N van den Brink; Leo L M Poon; Wilfred E Marissen; Cynthia S W Leung; Freek Cox; Chung Y Cheung; Arjen Q Bakker; Johannes A Bogaards; Els van Deventer; Wolfgang Preiser; Hans Wilhelm Doerr; Vincent T Chow; John de Kruif; Joseph S M Peiris; Jaap Goudsmit
Journal:  PLoS Med       Date:  2006-07       Impact factor: 11.069

4.  Seasonality and immunity to laboratory-confirmed seasonal coronaviruses (HCoV-NL63, HCoV-OC43, and HCoV-229E): results from the Flu Watch cohort study.

Authors:  Robert W Aldridge; Dan Lewer; Sarah Beale; Anne M Johnson; Maria Zambon; Andrew C Hayward; Ellen B Fragaszy
Journal:  Wellcome Open Res       Date:  2020-12-10

5.  A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2.

Authors:  Alba Grifoni; John Sidney; Yun Zhang; Richard H Scheuermann; Bjoern Peters; Alessandro Sette
Journal:  Cell Host Microbe       Date:  2020-03-16       Impact factor: 21.023

6.  Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV.

Authors:  Xiuyuan Ou; Yan Liu; Xiaobo Lei; Pei Li; Dan Mi; Lili Ren; Li Guo; Ruixuan Guo; Ting Chen; Jiaxin Hu; Zichun Xiang; Zhixia Mu; Xing Chen; Jieyong Chen; Keping Hu; Qi Jin; Jianwei Wang; Zhaohui Qian
Journal:  Nat Commun       Date:  2020-03-27       Impact factor: 14.919

7.  Epidemiology of Seasonal Coronaviruses: Establishing the Context for the Emergence of Coronavirus Disease 2019.

Authors:  Sema Nickbakhsh; Antonia Ho; Diogo F P Marques; Jim McMenamin; Rory N Gunson; Pablo R Murcia
Journal:  J Infect Dis       Date:  2020-06-16       Impact factor: 5.226

8.  Coronavirus Occurrence and Transmission Over 8 Years in the HIVE Cohort of Households in Michigan.

Authors:  Arnold S Monto; Peter M DeJonge; Amy P Callear; Latifa A Bazzi; Skylar B Capriola; Ryan E Malosh; Emily T Martin; Joshua G Petrie
Journal:  J Infect Dis       Date:  2020-06-16       Impact factor: 5.226

9.  Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.

Authors:  Alexandra C Walls; Young-Jun Park; M Alejandra Tortorici; Abigail Wall; Andrew T McGuire; David Veesler
Journal:  Cell       Date:  2020-03-09       Impact factor: 41.582

10.  Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity.

Authors:  Ellen Shrock; Eric Fujimura; Tomasz Kula; Richard T Timms; I-Hsiu Lee; Yumei Leng; Matthew L Robinson; Brandon M Sie; Mamie Z Li; Yuezhou Chen; Jennifer Logue; Adam Zuiani; Denise McCulloch; Felipe J N Lelis; Stephanie Henson; Daniel R Monaco; Meghan Travers; Shaghayegh Habibi; William A Clarke; Patrizio Caturegli; Oliver Laeyendecker; Alicja Piechocka-Trocha; Jonathan Z Li; Ashok Khatri; Helen Y Chu; Alexandra-Chloé Villani; Kyle Kays; Marcia B Goldberg; Nir Hacohen; Michael R Filbin; Xu G Yu; Bruce D Walker; Duane R Wesemann; H Benjamin Larman; James A Lederer; Stephen J Elledge
Journal:  Science       Date:  2020-09-29       Impact factor: 63.714

View more
  313 in total

1.  How kids' immune systems can evade COVID.

Authors:  Bianca Nogrady
Journal:  Nature       Date:  2020-12       Impact factor: 49.962

2.  How COVID-19 is changing the cold and flu season.

Authors:  Nicola Jones
Journal:  Nature       Date:  2020-12       Impact factor: 49.962

3.  Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses.

Authors:  Arbor G Dykema; Boyang Zhang; Bezawit A Woldemeskel; Caroline C Garliss; Laurene S Cheung; Dilshad Choudhury; Jiajia Zhang; Luis Aparicio; Sadhana Bom; Rufiaat Rashid; Justina X Caushi; Emily Han-Chung Hsiue; Katherine Cascino; Elizabeth A Thompson; Abena K Kwaa; Dipika Singh; Sampriti Thapa; Alvaro A Ordonez; Andrew Pekosz; Franco R D'Alessio; Jonathan D Powell; Srinivasan Yegnasubramanian; Shibin Zhou; Drew M Pardoll; Hongkai Ji; Andrea L Cox; Joel N Blankson; Kellie N Smith
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 14.808

4.  Virological Characteristics of Hospitalized Children With SARS-CoV-2 Infection.

Authors:  Swetha G Pinninti; Sunil Pati; Claudette Poole; Misty Latting; Maria C Seleme; April Yarbrough; Nitin Arora; William J Britt; Suresh Boppana
Journal:  Pediatrics       Date:  2021-02-23       Impact factor: 7.124

5.  Differential Performance of CoronaCHEK SARS-CoV-2 Lateral Flow Antibody Assay by Geographic Origin of Samples.

Authors:  Owen R Baker; M Kate Grabowski; Ronald M Galiwango; Aminah Nalumansi; Jennifer Serwanga; William Clarke; Yu-Hsiang Hsieh; Richard E Rothman; Reinaldo E Fernandez; David Serwadda; Joseph Kagaayi; Tom Lutalo; Steven J Reynolds; Pontiano Kaleebu; Thomas C Quinn; Oliver Laeyendecker
Journal:  J Clin Microbiol       Date:  2021-06-18       Impact factor: 5.948

6.  Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions.

Authors:  Andrea R Shiakolas; Kevin J Kramer; Daniel Wrapp; Simone I Richardson; Alexandra Schäfer; Steven Wall; Nianshuang Wang; Katarzyna Janowska; Kelsey A Pilewski; Rohit Venkat; Robert Parks; Nelia P Manamela; Nagarajan Raju; Emilee Friedman Fechter; Clinton M Holt; Naveenchandra Suryadevara; Rita E Chen; David R Martinez; Rachel S Nargi; Rachel E Sutton; Julie E Ledgerwood; Barney S Graham; Michael S Diamond; Barton F Haynes; Priyamvada Acharya; Robert H Carnahan; James E Crowe; Ralph S Baric; Lynn Morris; Jason S McLellan; Ivelin S Georgiev
Journal:  Cell Rep Med       Date:  2021-05-21

7.  Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection.

Authors:  Ge Song; Wan-Ting He; Sean Callaghan; Fabio Anzanello; Deli Huang; James Ricketts; Jonathan L Torres; Nathan Beutler; Linghang Peng; Sirena Vargas; Jon Cassell; Mara Parren; Linlin Yang; Caroline Ignacio; Davey M Smith; James E Voss; David Nemazee; Andrew B Ward; Thomas Rogers; Dennis R Burton; Raiees Andrabi
Journal:  Nat Commun       Date:  2021-05-19       Impact factor: 14.919

8.  SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity.

Authors:  Annachiara Rosa; Valerie E Pye; Carl Graham; Luke Muir; Jeffrey Seow; Kevin W Ng; Nicola J Cook; Chloe Rees-Spear; Eleanor Parker; Mariana Silva Dos Santos; Carolina Rosadas; Alberto Susana; Hefin Rhys; Andrea Nans; Laura Masino; Chloe Roustan; Evangelos Christodoulou; Rachel Ulferts; Antoni G Wrobel; Charlotte-Eve Short; Michael Fertleman; Rogier W Sanders; Judith Heaney; Moira Spyer; Svend Kjær; Andy Riddell; Michael H Malim; Rupert Beale; James I MacRae; Graham P Taylor; Eleni Nastouli; Marit J van Gils; Peter B Rosenthal; Massimo Pizzato; Myra O McClure; Richard S Tedder; George Kassiotis; Laura E McCoy; Katie J Doores; Peter Cherepanov
Journal:  Sci Adv       Date:  2021-05-28       Impact factor: 14.136

9.  Decay of Fc-dependent antibody functions after mild to moderate COVID-19.

Authors:  Wen Shi Lee; Kevin John Selva; Samantha K Davis; Bruce D Wines; Arnold Reynaldi; Robyn Esterbauer; Hannah G Kelly; Ebene R Haycroft; Hyon-Xhi Tan; Jennifer A Juno; Adam K Wheatley; P Mark Hogarth; Deborah Cromer; Miles P Davenport; Amy W Chung; Stephen J Kent
Journal:  Cell Rep Med       Date:  2021-05-09

10.  The impact of school reopening on the spread of COVID-19 in England.

Authors:  Matt J Keeling; Michael J Tildesley; Benjamin D Atkins; Bridget Penman; Emma Southall; Glen Guyver-Fletcher; Alex Holmes; Hector McKimm; Erin E Gorsich; Edward M Hill; Louise Dyson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2021-05-31       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.